Kerala draws ₹713 crore life sciences pledges at Bio Connect 4.0 conclave
Synopsis
Key Takeaways
The Kerala government secured investment pledges worth ₹713 crore in the life sciences and biomedical sectors at Bio Connect 4.0, a two-day International Life Sciences Industries Expo and Conclave that concluded in Thiruvananthapuram on 10 October 2026. The event was organised by the state-owned Kerala State Industrial Development Corporation (KSIDC) as part of a broader push to establish Kerala as a premier hub for innovation-driven life sciences industries.
Key Outcomes from Bio Connect 4.0
The conclave resulted in the signing of three memorandums of understanding (MoUs) and the submission of four expressions of interest (EoIs) by companies and institutions active in the sector. More than 600 delegates and over 45 exhibitors participated, bringing together industry players, researchers, and investors from across the country and abroad. The participating organisations spanned both leading public institutions and private enterprises.
What KSIDC Said
Snehil Kumar Singh, Managing Director of KSIDC, said Kerala needed to move beyond manufacturing and strengthen the entire life sciences value chain — from research and development to validation, commercialisation, and access to global markets. 'The state's objective was not merely to attract investment but to build an ecosystem where research generates innovation, companies create jobs and new technologies deliver solutions for society,' he said.
Sectors and Themes in Focus
The conclave explored opportunities in emerging areas including artificial intelligence, advanced therapies, nutraceuticals, next-generation biologics, and scientific research. A key theme was the need for closer collaboration between research institutions and industry to translate scientific advances into commercially viable products — a gap that has historically slowed life sciences growth in India's southern states.
Government Initiatives Backing the Push
The Kerala government is promoting the sector through flagship initiatives including the Bio360 Life Sciences Park and SARAL Kerala, alongside investment facilitation measures designed to lower barriers for life sciences enterprises. The investment commitments are expected to expand research-driven industries and build a stronger ecosystem for innovation, manufacturing, and commercialisation of life sciences products. The state hopes this initiative will encourage new enterprises, strengthen existing capabilities, and help Kerala emerge as a competitive centre for life sciences research and industrial development.